![Barbara Lambert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Lambert
Directeur/Bestuurslid bij
DEUTSCHE BÖRSE AG
Vermogen: 915 429 $ op 31-05-2026
Profiel
Barbara Lambert currently works at Implenia AG, as Independent Non-Executive Director from 2019, UBS Switzerland AG, as Independent Director from 2022, Deutsche Börse AG, as Independent Member-Supervisory Board from 2018, SYNLAB International GmbH, as Member-Supervisory Board, Isarsmaragd AG, as Member-Supervisory Board, and Merck KGaA, as Member-Supervisory Board from 2023.
Ms. Lambert also formerly worked at Ernst & Young AG, as Director, Head-Banking & Insurance Auditing from 2002 to 2007, Credit Suisse (Schweiz) AG, as Director, Banque Pictet & Cie SA, as Group Chief Risk Officer from 2014 to 2018, Arthur Andersen AG, as Partner from 1987 to 2002, and Synlab AG, as Independent Member-Supervisory Board from 2021 to 2024.
Ms. Lambert received her undergraduate degree in 1987 from the University of Geneva.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMPLENIA AG 0,06% | 05-01-2026 | 11.745 ( 0,06% ) | 915 429 $ | 31-05-2026 |
Actieve functies van Barbara Lambert
| Bedrijven | Functie | Begin |
|---|---|---|
| DEUTSCHE BÖRSE AG | Directeur/Bestuurslid | 16-05-2018 |
| IMPLENIA AG | Directeur/Bestuurslid | 26-03-2019 |
| MERCK KGAA | Directeur/Bestuurslid | 11-08-2023 |
Isarsmaragd AG | Directeur/Bestuurslid | - |
SYNLAB International GmbH
 SYNLAB International GmbH Medical/Nursing ServicesHealth Services Provides medical diagnostic laboratory services | Directeur/Bestuurslid | - |
UBS Switzerland AG
 UBS Switzerland AG Major BanksFinance Provides retail and corporate banking & wealth management services | Directeur/Bestuurslid | 05-04-2022 |
Eerdere bekende functies van Barbara Lambert
| Bedrijven | Functie | Einde |
|---|---|---|
| SYNLAB AG | Directeur/Bestuurslid | 01-03-2024 |
Banque Pictet & Cie SA
 Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie constructs portfolios of investments in large companies with stable earnings, balanced by shorter-term positions in stocks that have been mispriced or have the potential for recovery for bonds and equities. The fixed-income component generally includes core holdings of investment-grade sovereign debt and corporate bonds, complemented by opportunistic investments in high-yield corporate bonds and local currency emerging-market debt. Their fund mandates are managed by the team responsible for discretionary portfolios of mutual funds, exchange-traded funds and other pooled vehicles, operating on the principle of open architecture, selecting best-in-class Pictet or external funds. The firm also offers special mandates, such as absolute return mandates. | Comptroller/Controller/Auditor | 01-01-2013 |
Ernst & Young AG
 Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Directeur/Bestuurslid | 01-01-2007 |
| ░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Opleiding van Barbara Lambert
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Banque Pictet & Cie SA
Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie constructs portfolios of investments in large companies with stable earnings, balanced by shorter-term positions in stocks that have been mispriced or have the potential for recovery for bonds and equities. The fixed-income component generally includes core holdings of investment-grade sovereign debt and corporate bonds, complemented by opportunistic investments in high-yield corporate bonds and local currency emerging-market debt. Their fund mandates are managed by the team responsible for discretionary portfolios of mutual funds, exchange-traded funds and other pooled vehicles, operating on the principle of open architecture, selecting best-in-class Pictet or external funds. The firm also offers special mandates, such as absolute return mandates. | Finance |
Deutsche Börse AG
 Deutsche Börse AG Investment Banks/BrokersFinance Provides financial instruments trading and clearing, investment management solutions, securities and fund services | Finance |
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young AG
Ernst & Young AG Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Implenia AG
 Implenia AG Engineering & ConstructionIndustrial Services Provides construction services | Industrial Services |
Arthur Andersen AG
 Arthur Andersen AG Miscellaneous Commercial ServicesCommercial Services Part of Arthur Andersen LLP, Arthur Andersen AG is a company based in Geneva, Switzerland. | Commercial Services |
SYNLAB International GmbH
SYNLAB International GmbH Medical/Nursing ServicesHealth Services Provides medical diagnostic laboratory services | Health Services |
UBS Switzerland AG
UBS Switzerland AG Major BanksFinance Provides retail and corporate banking & wealth management services | Finance |
Credit Suisse (Schweiz) AG
 Credit Suisse (Schweiz) AG Investment Banks/BrokersFinance Provides private banking and wealth management services | Finance |
Synlab AG
 Synlab AG Medical/Nursing ServicesHealth Services Functions as a holding company whose subsidiaries provides clinical laboratory testing services | Health Services |
Isarsmaragd AG |
